PPARGC1A and metabolic disease: This study found that graphene-FIR therapy could activate the thermogenic program in adipose tissue, increasing the protein expression of AMPK/SIRT1/PGC-1α in adipose tissue (iWAT and BAT) and improving metabolic disorders in HFD mice.